Windlas Biotech Limited (WINDLAS) — Cash Flow Reinvestment Rate

Latest as of December 2023: 0.00x

Windlas Biotech Limited (WINDLAS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs67.78 Million. Explore Windlas Biotech Limited capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Rs0.00
Capex + Investments

Operating Cash Flow

Rs67.78 Million
INR

Capital Expenditures

Rs0.00
INR

Windlas Biotech Limited Cash Flow Reinvestment Rate (2018–2025)

Historical reinvestment intensity for Windlas Biotech Limited across 8 annual periods. Also explore how large is Windlas Biotech Limited's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Windlas Biotech Limited (2018–2025)

Year-by-year capital reinvestment analysis for Windlas Biotech Limited. For live market cap and broader valuation context, see WINDLAS stock market capitalisation.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2025 1.85x Rs1.26 Billion Rs681.87 Million Rs521.94 Million ▲ +55.5%
2024 1.19x Rs1.30 Billion Rs1.09 Billion Rs376.84 Million ▼ -14.6%
2023 1.39x Rs850.00 Million Rs609.65 Million Rs708.90 Million ▼ -91.9%
2022 17.22x Rs1.57 Billion Rs91.30 Million Rs148.04 Million ▲ +111.4%
2021 8.15x Rs933.19 Million Rs114.54 Million Rs58.47 Million ▲ +1227.6%
2020 0.61x Rs153.46 Million Rs250.06 Million Rs153.10 Million ▼ -5.3%
2019 0.65x Rs120.83 Million Rs186.54 Million Rs89.54 Million ▼ -51.6%
2018 1.34x Rs395.65 Million Rs295.91 Million Rs257.82 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow